204 related articles for article (PubMed ID: 37380085)
21. Circ-EPB41L5 regulates the host gene
Lv T; Miao Y; Xu T; Sun W; Sang Y; Jia F; Zhang X
Aging (Albany NY); 2020 Jan; 12(1):318-339. PubMed ID: 31905344
[TBL] [Abstract][Full Text] [Related]
22. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control.
Taheriazam A; Bayanzadeh SD; Heydari Farahani M; Mojtabavi S; Zandieh MA; Gholami S; Heydargoy MH; Jamali Hondori M; Kangarloo Z; Behroozaghdam M; Khorrami R; Sheikh Beig Goharrizi MA; Salimimoghadam S; Rashidi M; Hushmandi K; Entezari M; Hashemi M
Eur J Pharmacol; 2023 Jul; 951():175781. PubMed ID: 37179043
[TBL] [Abstract][Full Text] [Related]
23. Functions and mechanisms of miR-186 in human cancer.
Wang Z; Sha HH; Li HJ
Biomed Pharmacother; 2019 Nov; 119():109428. PubMed ID: 31525641
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS; Dutta A
Curr Opin Investig Drugs; 2006 Jun; 7(6):560-4. PubMed ID: 16784027
[TBL] [Abstract][Full Text] [Related]
25. The Roles of miR-25 and its Targeted Genes in Development of Human Cancer.
Caiazza C; Mallardo M
Microrna; 2016; 5(2):113-119. PubMed ID: 27594089
[TBL] [Abstract][Full Text] [Related]
26. Identification and Expression of Several Circular RNAs and Knockdown of hsa_circ_0005556 Exerts Oncogenic Functions by miR-767-5p in Gastric Cancer.
Geng H; Li K; Pan Q; Tao S; Li C; Zhao H; Zhao X
Med Sci Monit; 2020 Jul; 26():e921163. PubMed ID: 32728015
[TBL] [Abstract][Full Text] [Related]
27. Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis.
Moriondo G; Scioscia G; Soccio P; Tondo P; De Pace CC; Sabato R; Foschino Barbaro MP; Lacedonia D
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682972
[TBL] [Abstract][Full Text] [Related]
28. The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process.
Ghafouri-Fard S; Abak A; Tondro Anamag F; Shoorei H; Majidpoor J; Taheri M
Biomed Pharmacother; 2021 May; 137():111279. PubMed ID: 33493969
[TBL] [Abstract][Full Text] [Related]
29. Microrna-96 In Human Cancers.
Wu Y; Xie Z; Deng S; Xia Y; Lei X; Yang X
Comb Chem High Throughput Screen; 2023; 26(7):1285-1297. PubMed ID: 36093821
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-224: as a potential target for miR-based therapy of cancer.
Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
[TBL] [Abstract][Full Text] [Related]
31. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
[TBL] [Abstract][Full Text] [Related]
32. OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy.
Zheng N; Yang P; Wang Z; Zhou Q
Curr Cancer Drug Targets; 2017; 17(1):40-47. PubMed ID: 26881930
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of miR-638 in the progression of cancers.
Chong ZX; Yeap SK; Ho WY
Pathol Res Pract; 2021 Apr; 220():153351. PubMed ID: 33642053
[TBL] [Abstract][Full Text] [Related]
34. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment.
Moles R
Microrna; 2017 Aug; 6(2):102-109. PubMed ID: 28699479
[TBL] [Abstract][Full Text] [Related]
36. An updated review of contribution of long noncoding RNA-NEAT1 to the progression of human cancers.
Farzaneh M; Masoodi T; Ghaedrahmati F; Radoszkiewicz K; Anbiyaiee A; Sheykhi-Sabzehpoush M; Rad NK; Uddin S; Jooybari SPM; Khoshnam SE; Azizidoost S
Pathol Res Pract; 2023 May; 245():154380. PubMed ID: 37043964
[TBL] [Abstract][Full Text] [Related]
37. Dual role of microRNA-1297 in the suppression and progression of human malignancies.
Alizadeh-Fanalou S; Khosravi M; Alian F; Rokhsartalb-Azar S; Nazarizadeh A; Karimi-Dehkordi M; Mohammadi F
Biomed Pharmacother; 2021 Sep; 141():111863. PubMed ID: 34243098
[TBL] [Abstract][Full Text] [Related]
38. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review.
Kouchaki H; Kamyab P; Darbeheshti F; Gharezade A; Fouladseresht H; Tabrizi R
J Egypt Natl Canc Inst; 2024 Apr; 36(1):16. PubMed ID: 38679648
[TBL] [Abstract][Full Text] [Related]
39. Regulation of Autophagy by MiRNAs and Their Emerging Roles in Tumorigenesis and Cancer Treatment.
Chen L; Zhou Y; Sun Q; Zhou J; Pan H; Sui X
Int Rev Cell Mol Biol; 2017; 334():1-26. PubMed ID: 28838537
[TBL] [Abstract][Full Text] [Related]
40. Potentials of lncRNA-miRNA-mRNA networks as biomarkers for laryngeal squamous cell carcinoma.
Lv Y; Wang Y; Zhang Z
Hum Cell; 2023 Jan; 36(1):76-97. PubMed ID: 36181662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
